Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL708256

Cn1ccnc1COc1cc(OCc2c(F)cccc2F)cc(-c2nc3cccnc3[nH]2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GUCY1B2 O75343 6/20 0.36
GUCY1A2 P33402 6/20 0.36
GUCY1A1 Q02108 6/20 0.36
GUCY1B1 Q02153 6/20 0.36
PPARG P37231 3/20 0.35
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 1/20 0.33
SCN9A Q15858 1/20 0.33
SCN10A Q9Y5Y9 1/20 0.33
SYK P43405 1/20 0.33
GPR6 P46095 1/20 0.33
SLC16A3 O15427 1/20 0.33
SLC16A1 P53985 1/20 0.33
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10206667 0.93 MEN1 (0.36) GUCY1B2GUCY1A2GUCY1A1GUCY1B1PPARG
Trifluoroacetic Acid SCHEMBL712600 0.89 FAAH (0.38) SYK
Trifluoroacetic Acid SCHEMBL709575 0.89 SYK (0.34) PPARGCASP3SENP8SENP6KDM4E
Trifluoroacetic Acid SCHEMBL713293 0.88 MEN1 (0.36) PPARGCASP3SENP8SENP6KDM4E
Trifluoroacetic Acid SCHEMBL711504 0.87 NOS1 (0.35) KDM4EMEN1KMT2ASYKGPR6
Trifluoroacetic Acid SCHEMBL709074 0.87 NAMPT (0.36) CASP3SENP8SENP6KDM4EMEN1
Trifluoroacetic Acid SCHEMBL718789 0.87 PDE4A (0.35) PPARGKDM4EMEN1KMT2ASYK
Trifluoroacetic Acid SCHEMBL711518 0.86 PDE4A (0.36) HTT
Trifluoroacetic Acid SCHEMBL712920 0.86 KDM4E (0.38) PPARGKDM4E
Trifluoroacetic Acid SCHEMBL711889 0.86 HDAC3 (0.34) SYKSLC16A3SLC16A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK GUCY1B2 1111/4885GUCY1A2 1185/4885GUCY1A1 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.